Pimsiri Sripongpun
- Hepatology top 5%
- Liver Disease and Transplantation 15
- Hepatitis C virus research 12
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Liver Diseases and Immunity 7
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 40
- Hepatitis B Virus Studies 18
-
- Pancreatic and Hepatic Oncology Research 6
-
- Gallbladder and Bile Duct Disorders 5
Pimsiri Sripongpun
59 papers receiving 435 citations
Peers
Comparison fields: 5 of 55
- Hepatology 251
- Epidemiology 319
- Endocrinology, Diabetes and Metabolism 53
- Gastroenterology 11
- Physiology 48
Countries citing papers authored by Pimsiri Sripongpun
This map shows the geographic impact of Pimsiri Sripongpun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pimsiri Sripongpun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pimsiri Sripongpun more than expected).
Fields of papers citing papers by Pimsiri Sripongpun
This network shows the impact of papers produced by Pimsiri Sripongpun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pimsiri Sripongpun. The network helps show where Pimsiri Sripongpun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pimsiri Sripongpun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 16 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 9 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 1 | |
| 16 | 2022 | 13 | |
| 17 | 2022 | 10 | |
| 18 | 2022 | 58 | |
| 19 | 2020 | 6 | |
| 20 | 2019 | 5 |
About Pimsiri Sripongpun
Pimsiri Sripongpun is a scholar working on Hepatology, Epidemiology and Gastroenterology, having authored 65 papers that have together received 446 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (40 papers), Hepatitis B Virus Studies (18 papers), Liver Disease and Transplantation (15 papers), Hepatitis C virus research (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Diseases and Immunity (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Gallbladder and Bile Duct Disorders (5 papers). The work is most often cited by research in Hepatology (251 citations), Epidemiology (319 citations) and Endocrinology, Diabetes and Metabolism (53 citations). Pimsiri Sripongpun has collaborated with scholars based in Thailand, United States and Singapore. Frequent co-authors include Apichat Kaewdech, Naichaya Chamroonkul, Teerha Piratvisuth, W. Ray Kim, Ajitha Mannalithara, Chanon Kongkamol, Chaitong Churuangsuk, Allison J. Kwong, Panu Wetwittayakhlang and Steven M. Asch.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.